June 17, 2026

TRIPURA STAR NEWS

Tripura's Latest News, Views & News Portal

TruNativ Secures $30 Million Funding From Orbimed To Accelerate Expansion.

Spread the love

Mumbai, Maharashtra, 17th of June 2026 : TruNativ, a science-backed everyday nutrition company, today announced the close of its funding round of ~$30M, led by OrbiMed, one of the world’s largest dedicated healthcare investment firms. The Series B funding round comprised both primary investment and the sale of secondary shares of early investors. The investment marks a significant milestone in TruNativ’s journey to build India’s most trusted nutrition platform and strengthen access to clean, science-backed nutrition solutions for consumers across the country.

The newly raised capital will be deployed across strategic priorities: a nationwide distribution expansion across D2C, quick commerce, modern trade, pharmacy and other retail channels; and the continued expansion of TruNativ’s B2B2C ingredient business, which currently powers nutrition solutions for several leading consumer brands in India.

Founded by mother-son duo Pranav Malhotra and Mamta Malhotra in 2019 in Mumbai, TruNativ has grown from a single sugar-replacement product into a clean-label nutrition platform spanning sugar alternatives, protein, gut health, and wellness. The brand currently holds a majority share of the sugar replacement category on quick-commerce platforms and ranks No. 1 in the dietary fibre and sweeteners categories on Amazon India.

Pranav Malhotra, Co-Founder & CEO, TruNativ, said: “India’s nutrition transformation is not a trend, it is a reckoning. For decades, Indian consumers have been underserved: overexposed to sugar, protein deficiency, and dependent on products that promise health but deliver compromise. We built TruNativ to fix that for every household, not just the health-conscious few. OrbiMed’s investment signals that preventive nutrition is no longer a wellness trend — it is a healthcare imperative. Our commitment is to make India a global leader in nutrition innovation, not just a consumer of it.”

Commenting on the investment, Dr. Sunny Sharma, Senior Managing Director, OrbiMed Asia said, “We share Pranav’s passion for improving nutrition nationwide and enhancing health outcomes through healthier daily dietary habits. OrbiMed is excited to partner with TruNativ as it builds a leading consumer health business.” Dr. Sharma and Sumona Chakraborty of OrbiMed will be joining the company’s board.

OrbiMed’s investment reflects growing confidence in India’s nutrition and preventive healthcare ecosystem. As consumers increasingly prioritize healthier lifestyles and proactive wellness, demand for clean-label, science-backed nutrition solutions continues to accelerate. With its strong category leadership and innovation-led approach, TruNativ is well-positioned to capitalise on this opportunity and shape the future of everyday nutrition in India.

PwC acted as exclusive financial advisor to TruNativ on this transaction.

About TruNativ

TruNativ® (Tru Native F&B Pvt. Ltd.) is a science-backed everyday nutrition company. Built on the philosophy that nutrition should be simple, accessible, and trustworthy, TruNativ operates across five high-growth nutrition categories: sugar substitution (Everyday Sweet™), protein (Everyday Protein, Pro Blend Whey), gut health (Everyday Fiber), beauty wellness (Advanced Collagen), and performance nutrition. The company distributes across D2C, Q-commerce, modern trade, HoReCa, and B2B ingredient supply — and powers nutrition solutions for leading Indian consumer brands. TruNativ is headquartered in Mumbai, India.

About OrbiMed

OrbiMed is one of the world’s largest dedicated healthcare investment firms, managing about $20 billion in assets across public equities, private equity, venture capital, and royalty strategies. OrbiMed invests globally in companies developing transformative solutions across biotechnology, pharmaceuticals, medical devices, and healthcare services.

About The Author